CCR5 is a prognostic biomarker and an immune regulator for triple negative breast cancer

This study aims to explore the clinical implications and potential mechanistic functions of CCR5 in triple negative breast cancer. Briefly, we demonstrated that CCR5 is overexpressed in TNBC and is associated with better prognosis of TNBC. CCR5 expression is positively correlated with tumor immune c...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xin, Han, Yong, Peng, Jiamin, He, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580338/
https://www.ncbi.nlm.nih.gov/pubmed/34717291
http://dx.doi.org/10.18632/aging.203654

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580338/
https://www.ncbi.nlm.nih.gov/pubmed/34717291
http://dx.doi.org/10.18632/aging.203654

Ejemplares similares